VJHemOnc is committed to improving our service to you

IMW 2019 | Issues within maintenance therapy standardization in MM

VJHemOnc is committed to improving our service to you

Giadi Bianchi

Giada Bianchi, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the financial and geographical implications of the availability of maintenance therapy drugs for multiple myeloma (MM), speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter